CamDiab

CamDiab Ltd is a digital health and personalized medicine company based in London, founded in 2018. The company specializes in advanced diabetes management technology, aiming to improve the lives of individuals with type 1 diabetes through innovative software solutions. The flagship product, CamAPS FX, is a hybrid closed-loop app that automates insulin delivery using an adaptive, self-learning control algorithm. This app works with compatible continuous glucose monitoring devices and insulin pumps to autonomously calculate and adjust insulin doses, helping users maintain optimal glycemic levels. CamDiab's technology has been validated through extensive clinical trials and has received regulatory approvals in multiple regions, including the EU, UK, New Zealand, Australia, Canada, and the United States. CamDiab collaborates with partners like Ypsomed to enhance smartphone-based automated insulin delivery systems. The company is dedicated to providing reliable, user-friendly digital health solutions that support people with type 1 diabetes and their families in managing their condition effectively.

• Employees 9
• Founded 2018